Growing Prevalence Of Different Types Of Cancers To Uplift The Growth Of The Dual Specificity Protein Kinase TTK Market
The growing prevalence of different types of cancers around the globe is one of the prime factors driving the growth of the dual specificity protein kinase TTK market. Cancers such as breast cancer, solid tumor, metastatic breast cancer, colorectal cancer, pancreatic ductal adenocarcinoma, and prostate cancer are highly prevalent across developed countries. According to Cancer Research UK, it is expected that around 17 million new cases of cancer will be registered across the globe in 2018. Moreover, as per the U.S. National Library of Medicine and National Institutes of Health, pancreatic ductal adenocarcinoma is one of the most lethal cancers worldwide with the highest incidence rates found in North America and in Western Europe while lower rates in Asian Africa, with the incidence rates of 7.2 and 2.8 per 100,000 populations, respectively in 2017. Furthermore, a growing number of pipeline molecules of dual-specificity protein kinase TTK as a targeted drug for different types...